Current Cancer Therapy Reviews
Volume 15, 3 Issues, 2019
ISSN: 1875-6301 (Online)
ISSN: 1573-3947 (Print)
This journal supports open access
ISSN: 1875-6301 (Online)
ISSN: 1573-3947 (Print)
This journal supports open access
Contents
Current Cancer Therapy Reviews, Volume 2 - Number 3
Biological Basis of Novel Therapies for Myelodysplastic Syndrome
, 2(3): 199 - 209Eyal C. Attar and Karen K. Ballen
DOI: 10.2174/157339406777934708
Current Treatment of Relapsed Ovarian Carcinoma
, 2(3): 211 - 221Aristotle Bamias, Alexandros Rodolakis and Meletios A. Dimopoulos
DOI: 10.2174/157339406777934726
Lenalidomide: Cancer Therapy via Antiangiogenesis and Immunomodulation
, 2(3): 223 - 229Tanyifor M. Tohny, Jurgen Venitz, Alex Sparreboom and William D. Figg
DOI: 10.2174/157339406777934690
A Role for Tumor Suppressor Protein p53 in the Fidelity of DNA Synthesis and Resistance Towards Nucleoside Analogs
, 2(3): 231 - 241Mary Bakhanashvili and Galia Rahav
DOI: 10.2174/157339406777934672
Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells
, 2(3): 255 - 270Caryl J. Giuliano, Sarah J. Freemantle and Michael J. Spinella
DOI: 10.2174/157339406777934681
Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy
, 2(3): 271 - 279Yong Wang, Virginia Probin and Daohong Zhou
DOI: 10.2174/157339406777934717
  |
Editor-in-Chief
Kurt S. Zaenker
Institute of Immunology and Experimental Oncology
Witten/Herdecke University
Stockumerstraße 10, 58448 Witten
Germany
Institute of Immunology and Experimental Oncology
Witten/Herdecke University
Stockumerstraße 10, 58448 Witten
Germany
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Cancer Therapy Reviews Journal was launched in 2005. Dr. Kurt S. Zaenker serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net